Examination of bcl‐2 and p53 expressions and apoptotic index by TUNEL method in psoriasis
Authors:
- 30 August 2006
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 33 (12) , 788-792
Abstract
Background: Psoriasis is characterised by hyperproliferation and by aberrant differentiation. Blockage of the normal apoptotic process is one of the factors implicated in the pathogenesis.Objective: To determine the apoptotic features by using TUNEL method and also bcl‐2 and p53 expressions in psoriatic epidermis.Materials and methods: Biopsies of 35 patients with psoriasis vulgaris and 14 normal skin were evaluated. Apoptotic cells were detected using the dUTP nick‐end labelling assay; bc1‐2 and p53 expressions were assessed by using immunohistochemical techniques. A semi‐quantitative grading system (HSCORE) was used for comparison.Results: Bcl‐2 was strongly expressed in basal keratinocytes of normal skin, while no expression was observed in 13 (37.2%) of the psoriatic samples and it was weakly expressed in the spinous cell layer of 22 (62.8%) samples. Moderate p53 expression was observed in the psoriasis group, while it was weak in the control. The percentage of TUNEL positive cells were significantly increased in the psoriasis group (65±2.30) when compared with the control (32.84±7.16).Conclusion: Apoptotic index besides bc1‐2 and p53 expressions in psoriasis differ from normal epidermis. Down‐regulation of bc1‐2 is consistent with the dynamics of psoriasis but increased TUNEL positive cells and p53 expression has not been fully elucidated yet.Keywords
This publication has 13 references indexed in Scilit:
- Analysis of p53 and bcl‐2 protein expression in the non‐tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesionsJournal of Cutaneous Pathology, 2004
- Evaluation of cell death and proliferation in psoriatic epidermisJournal of Dermatological Science, 2004
- Psoriatic architecture constructed by epidermal remodelingJournal of Dermatological Science, 2004
- Examination of Bcl‐2, Bcl‐X and bax protein expression in psoriasisInternational Journal of Dermatology, 2003
- Overexpression of bcl‐2 in lymphocytes of psoriatic skinJournal of the European Academy of Dermatology and Venereology, 2003
- Alteration of the Expression of Bcl-2, Bcl-x, Bax, Fas, and Fas Ligand in the Involved Skin of Psoriasis vulgaris following Topical Anthralin TherapySkin Pharmacology and Physiology, 2003
- Aberrant expression of apoptosis-related molecules in psoriatic epidermisJournal of Dermatological Science, 2002
- Expression of p53 Protein Before and After PUVA Treatment in PsoriasisActa Dermato-Venereologica, 1999
- Abnormal Bcl-2 and “Tissue” Transglutaminase Expression in Psoriatic SkinJournal of Investigative Dermatology, 1994
- Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesionsBritish Journal of Dermatology, 1994